---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-014262"
form_type: "8-K"
ticker: "GKOS"
cik: "0001192448"
company_name: "GLAUKOS Corp"
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T05:48:23.069080+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Glaukos Q3 revenue $96.7M (+24% YoY), raises 2024 guidance to $377-379M

## Summary
- Record Q3 net sales of $96.7M (+24% YoY); glaucoma segment $76.0M (+30%), corneal health $20.6M (+5%).
- GAAP net loss narrowed to $21.4M ($0.39 loss per share) from $30.4M ($0.63) in Q3 2023.
- Non-GAAP net loss $15.2M ($0.28 per share) vs $24.2M ($0.50) prior year.
- Raised FY2024 net sales guidance to $377M-$379M from prior $370M-$376M.
- Gross margin ~77%, non-GAAP ~82%; ended quarter with $267.2M cash.

## SEC filing metadata
- accession: 0001558370-24-014262
- form_type: 8-K
- ticker: GKOS
- cik: 0001192448
- company_name: GLAUKOS Corp
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1192448/000155837024014262/0001558370-24-014262-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1192448/000155837024014262/gkos-20241104x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-014262
- JSON: https://secwatch.observer/filing/0001558370-24-014262.json
- Plain text: https://secwatch.observer/filing/0001558370-24-014262.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.